@Article{chd.12851,
AUTHOR = {Ari Cedars, Luke Burchill, S. Lucy Roche, Jonathan Menachem, Kelly Axsom, Kristen Tecson},
TITLE = {Impact of durable ventricular assist devices on post‐transplant outcomes in adults with congenital heart disease},
JOURNAL = {Structural and Congenital Heart Disease},
VOLUME = {14},
YEAR = {2019},
NUMBER = {6},
PAGES = {958--962},
URL = {http://www.techscience.com/schd/v14n6/38919},
ISSN = {3071-1738},
ABSTRACT = {<b>Background:</b> There are no published data on post‐transplant outcomes in durable ven‐
tricular assist device (VAD)‐supported adult congenital heart disease (ACHD) patients.<br/>
<b>Methods:</b> We compared post‐transplant outcomes in VAD‐supported vs non‐VAD‐
supported ACHD patients using the Scientific Registry of Transplant Recipients.<br/>
<b>Results:</b> At 1 year, there was no difference in post‐transplant mortality between 
VAD‐supported (12 patients) and non‐VAD‐supported (671 patients) ACHD patients.<br/>
<b>Conclusions:</b> In appropriate ACHD patients, VAD use as a bridge to transplant is a 
reasonable strategy.},
DOI = {10.1111/chd.12851}
}